# H4D

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/h4d

- Industry: Healthcare IT
- Headquarters: Paris, France
- Website: www.h4d.com
- Total disclosed funding: $7.3M
- Latest round: Series B (Jul 12, 2016)
- Investors on record: 4

## About

H4D specializes in telemedicine solutions that enhance access to healthcare through innovative services like teleconsultation via specialized medical cabins, fostering connections between patients and trained physicians.H4D is a telemedicine company founded in 2008 and headquartered in Paris, France. The company has executed a total of 6 deals, with the most recent deal on June 1, 2020, in which it raised EUR 15 million from investors including Atoga, AVIVA France, Bpifrance, LBO France, and Supernova Invest. Franck Baudino is the founder of H4D, and the company has maintained its focus on providing telemedicine solutions since its inception.H4D provides innovative telemedicine solutions, bridging the gap between patients and healthcare providers. Their core offering includes teleconsultation services through specialized medical cabins, ensuring patient confidentiality while connecting them with trained physicians. The process is accessible and allows for comprehensive clinical diagnoses through certified medical devices linked to doctors remotely. H4D serves public health institutions, private enterprises, and individual patients in various European markets, leveraging partnerships with organizations like Inserm to facilitate the adoption of telemedicine.In 2023, H4D generated a revenue of EUR 2,723,715.40. The company reported an EBITDA of EUR -5,589,107.70 for the same year. H4D's revenue model focuses on B2B partnerships and direct-to-consumer transactions, collaborating with healthcare providers and municipalities to offer its telemedicine solutions, including the ConsultAccess® platform, a Class IIa medical device.H4D plans to utilize the EUR 15 million raised in June 2020 to further develop its telemedicine offerings and expand into new markets. There are forthcoming product launches designed to enhance their service capabilities, although specific release dates have not been disclosed. The company is targeting expansion into additional European markets to broaden its reach and enhance healthcare access, ensuring that its innovative solutions are available to a wider audience.

## Funding rounds

- Series B, Jul 12, 2016, $7.3M — CNP Assurances, Bpifrance, Innovation Capital, Atoga

## Investors

- CNP Assurances — Series B
- Bpifrance — Series B
- Innovation Capital — Series B
- Atoga — Series B